Clinical Trial Update: Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating lurasidone added to lithium or divalproex for maintenance treatment in Bipolar I Disorder; the study completed and results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• DEPAKOTE (DIVALPROEX SODIUM)
• Latuda (lurasidone)
• Lithium (Lithium carbonate)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Bipolar I Disorder | Phase 3 | Status: COMPLETED | Results posted: 2016-07-26